Skip to content

Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $20 Million Registered Direct Offering

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $5.6 Million Underwritten Public Offering of Common Stock

Sichenzia Ross Ference LLP Represents Medicine Man Technologies, Inc. in Private Placement Offering of up to $14 Million

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $3.0 Million Registered Direct Offering of Common Stock and Warrants of General Cannabis Corp.

Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.0 Million Public Offering of Common Stock of Medalist Diversified REIT, Inc.

Sichenzia Ross Ference LLP Announces $1.3 million Private Placement of Common Stock of Medalist Diversified REIT, Inc.

Sichenzia Ross Ference LLP Represents ThinkEquity in $2.0 Million Underwritten Public Offering of ADSs of Immuron Limited.

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares

Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement

Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $25 Million Credit Facility with East West Bank

Sichenzia Ross Ference LLP Represents LiveWell Canada Inc. in $15 Million Private Placements to Scale its CBD Operations

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $5.4 Million Public Offering of Common Stock of Opgen, Inc.

Sichenzia Ross Ference Represents Pareteum Corporation in $50 Million Credit Facility with Post Road Group

Sichenzia Ross Ference Represents Pareteum Corporation in Tender Offer for Shares of iPass, Inc. and Completes Acquisition

Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $6.5 Million Public Offering for Cellect Biotechnology Ltd.

Sichenzia Ross Ference LLP Represents INmune Bio Inc. in an $8 Million Initial Public Offering and Listing on the Nasdaq Capital Market

Sichenzia Ross Ference LLP Represents Boulder Botanicals & Biosciences Laboratories, Inc. in a $5.0 Million Private Placement

Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to China SXT Pharmaceuticals, Inc.’s $10.2 Million U.S. Initial Public Offering

Sichenzia Ross Ference LLP Represents New Age Beverages Corporation in the $85 Million Acquisition of Morinda Holdings, Inc.